WuXiPRA, a joint venture formed between WuXi and PRA, that offers  Phase I-IV clinical trial services in China, Hong Kong, and Macau, has recently  named Dr. James Pusey as president and general manager.

Pusey has more than 25 years of experience in medicine, international  clinical trial management, CRO services, and global pharmaceutical sales,  marketing, and clinical operations. Prior to joining WuXiPRA, Pusey was  founding CEO of Theorem Clinical Research, where he served as president and  chief executive officer, executive chairman, and board director from 2009  through 2013.

With Pusey’s leadership, WuXi’s local expertise, and PRA’s  leading-edge global systems and processes WuXiPRA is well positioned to support  its customers with the highest quality clinical trials in China for Chinese and  international regulatory filings.